Incidence and Outcomes of Upper GI Bleeding in Hospitalized SARS-CoV-2 Patients
Conclusions: Healthcare providers should be aware of the greater therapeutic needs of SARS-CoV-2–positive patients with UGB. Our data helps shed light on the relationship between SARS-CoV-2 and GI bleeding due to SARS-CoV-2–related tissue damage and treatment affecting the GI tract.
Saved in:
| Main Authors: | Erin Sanzone, Katherine Gheysens, Krystal Hunter, Adib Chaaya, Sangita Phadtare |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/grp/4358786 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastric Glomus Tumor: An Uncommon Source for an Acute Upper GI Bleed
by: Douglas Morte, et al.
Published: (2018-01-01) -
Frequency of mortality in patients with high AIMS65 score presenting with upper GI bleed
by: Javeria Zahid Khan, et al.
Published: (2023-01-01) -
Incidence, treatments, and outcomes of SARS-CoV-2 and HIV co-infections
by: Rini Chaturvedi, et al.
Published: (2021-12-01) -
Chemotherapy Used to Halt Lower GI Bleeding in a Rare Case of Metastatic Choriocarcinoma to the GI Tract
by: Ralph Kamel, et al.
Published: (2016-01-01) -
Serratia marcescens and its role in Pink breast milk and upper GI bleeding in an infant: a Tanzanian case report
by: Rukhsar Osman, et al.
Published: (2025-04-01)